Podcasts about neuroscience department

GDP Script/ Top Stories for January 30th Publish Date: January 30th From the BG AD Group Studio Welcome to the Gwinnett Daily Post Podcast. Today is Thursday, January 30th and Happy birthday to ***01.30.24 - BIRTHDAY – FRANKLIN D ROOSEVELT*** I’m Keith Ippolito and here are your top stories presented by KIA Mall of Georgia. City of Duluth Honored With 2025 Visionary City Award For Rogers Bridge Project Stephen Aaron running for 9th District GOP Chair Best Beer Festival: Here's How You Can Vote For Suwanee Beer Fest Plus, Leah McGrath from Ingles Markets on healthy alternatives All of this and more is coming up on the Gwinnett Daily Post podcast, and if you are looking for community news, we encourage you to listen daily and subscribe! Break 1: 07.14.22 KIA MOG STORY 1: City of Duluth Honored With 2025 Visionary City Award For Rogers Bridge Project The City of Duluth has received the 2025 Visionary City Award from the Georgia Municipal Association and Georgia Trend Magazine for its Rogers Bridge Project. Recognized in the Large Cities Category, the project connects Rogers Bridge Park in Duluth to Cauley Creek Park in Johns Creek, enhancing regional accessibility and sustainability. The pedestrian and cyclist bridge promotes active lifestyles and community collaboration. Duluth Mayor Greg Whitlock celebrated the honor, highlighting the city’s commitment to enriching lives and fostering unity. The award was presented at GMA’s Cities United Summit on Jan. 26. STORY 2: Stephen Aaron running for 9th District GOP Chair Ellijay resident Stephen Aaron has announced his candidacy for chairman of the 9th District Republican Party, which includes northern Gwinnett County. Currently serving as 1st Vice Chairman, Aaron aims to strengthen the party through leadership training, fundraising, and membership growth ahead of the 2026 election cycle. With 20 years of GOP involvement and experience on over 20 campaigns across eight states, Aaron emphasizes the importance of proactive efforts to maintain the district’s conservative values. The election will take place during the 9th District Convention on April 26. STORY 3: Best Beer Festival: Here's How You Can Vote For Suwanee Beer Fest The Suwanee American Craft Beer Fest has been nominated for the USA TODAY 10Best Readers’ Choice Award for Best Beer Festival. After winning in 2022 and placing runner-up the past two years, the festival is once again vying for the top spot. Known for its lively atmosphere, diverse craft beer selection, and community spirit, the event attracts beer enthusiasts from across the region. Voting is open daily until Feb. 24, with winners announced on March 5. Event Manager Tiffany Belflower expressed excitement about the nomination, highlighting the team’s dedication and attendee passion. We have opportunities for sponsors to get great engagement on these shows. Call 770.874.3200 for more info. We’ll be right back Break 2: 08.05.24 OBITS_FINAL STORY 4: Brightside Cafe Brightside Café, located at 554 West Main Street in Buford, has transformed a historic building into a community-focused coffee shop with a mission. Founded by Jennifer Elinburg and Carrie Walton, the café employs 22 special-needs individuals, offering them opportunities to build confidence and success. Open since December, the café serves coffee, smoothies, and baked goods while fostering meaningful interactions between employees and customers. A nonprofit, Brightside Forever Foundation, supports its operations and plans for a mobile trailer. With growing community support, the café continues to thrive, creating a space of inclusion and joy. STORY 5: Paul Duke STEM Senior Makes List Of Top Teen Scientists Chloe Au, a senior at Paul Duke STEM High School, has been named one of the top 300 scholars in the prestigious Regeneron Science Talent Search (STS) competition by the Society for Science. Her research, “The Role of Myc in Tunicate Central Nervous System Development,” earned her this recognition, along with a $2,000 award for herself and her school. Chloe, who interned with Georgia Tech’s Neuroscience Department, is passionate about neurodegeneration research inspired by personal experiences. Principal Dr. Jonathon Wetherington praised her achievement, highlighting the potential of high school students when given advanced research opportunities. Break 3: And now here is Leah McGrath from Ingles Markets on healthy alternatives ***INGLES ASK LEAH 2 HEALTHY ALTERNATIVES*** We’ll have closing comments after this Break 4: Ingles Markets 2 Signoff – Thanks again for hanging out with us on today’s Gwinnett Daily Post Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at www.gwinnettdailypost.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com www.wagesfuneralhome.com www.kiamallofga.com #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

More and more companies are starting to develop Software as Medical Devices (SAMD) and in this podcast episode, I have invited Weronika Michaluk to talk to us about some pitfalls that you need to avoid.  Weronika will talk about:  - Risk Management  - Usability  - Documentation  - Expertise  - Interoperability and scalability  - Cybersecurity.  So don't miss that and don't hesitate to contact Easy Medical Device if you have some questions.  Who is Weronika Michaluk?  Weronika Michaluk is an experienced professional with a diverse background in the fields of biomedical engineering, international business, and public health. She is a Biomedical Engineer by training, holds a Master's degree in International Business from the University of Miami, an MBA from the Warsaw School of Management, and a Doctorate in Public Health (DPH) with a specific focus on the business strategy of Agile Development of Software as a Medical Device (SaMD).  Weronika's career began as a Biomedical Engineer, where she contributed to the development of various biomedical devices, including a wireless ECG system, then she worked in South Korea in the Neuroscience Department and after that she focused on digital health solutions and consulting in the medical device space.    Currently, Weronika serves as the Digital Health Principal and SaMD Lead at HTD. In this role, she leads the Software as a Medical Device department, utilizing her expertise in biomedical engineering and business acumen. Her primary objective is to ensure that all products are meticulously designed and developed, adhering to the highest quality standards. Weronika's dedication to customer satisfaction and patient safety is instrumental in driving the success of the organization and its customers.     In her free time Weronika enjoys learning new languages (speaks 5 currently), travelling the world, playing sports, hiking ( she recently hiked Kilimanjaro, plans to hike to Mount Everest base camp next year) and discovering the unknown.  Who is Monir El Azzouzi?  Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.  Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  Link Weronika Michaluk LinkedIn Page:  https://www.linkedin.com/in/weronika-michaluk-mba-43811698/  HTD Health website: https://htdhealth.com/ Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice

Weronika Michaluk Digital Health Principal and SaMD Lead at HTD, a company specialising in the planning, designing and development of custom healthcare software. Weronika is an experienced professional with a diverse background in the fields of biomedical engineering, international business and public health. Her career began as a Biomedical Engineer, where she contributed to the development of various biomedical devices, including a wireless ECG system, then she worked in South Korea in the Neuroscience Department and after that, she focused on digital health solutions and consulting in the medical device space. In this episode, we delve into the world of software medical devices, explore the agile and waterfall approaches in software development and their application to regulated medical devices. We discover the crucial role of software in medical devices, uncover how some companies unintentionally market unregulated medical products and learn how to stay updated with the ever-evolving regulations. Timestamps: [00:00:10] What makes a software a Medical Device [00:05:57] Complexity of regulating software [00:11:52] Agile individuals and interactions over processes [00:17:30] Software medical device: engineering, research, business and coding [00:23:00] How to keep up with regulations Get in touch with Weronika Michaluk - https://www.linkedin.com/in/weronika-michaluk-mba-43811698/ https://htdhealth.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal --- Support this podcast: https://podcasters.spotify.com/pod/show/themedtechpodcast/support

Today's guest is Dr. Ameer Hassan, a triple board-certified neurologist who specializes in stroke, and is Head of the Neuroscience Department and a Professor of Neurology and Radiology at the University of TX Rio Grande Valley Dr. Hassan joined us for a Vascular Neurology Grand Rounds and stuck around to record this episode with one of our Vascular Neurology Fellows, Danish Kherani to answer some more questions so that we can share more of his insight and research.  ____________________________________ Twitter: @UTHealthStroke Instagram: @UTHealthStroke Facebook: facebook.com/uthealthstroke LinkedIn: linkedin.com/company/uthealth-stroke Ideas and opinions are our own and this podcast is not a substitute for expert medical advice. About StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news on stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many of who are experts in their field, to discuss their practice, cutting-edge research, and medical care. Who We Are The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation. Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs. Contact For more information or if you have any questions, please contact us at ⁠info.uthiscd@gma⁠il.com

This week, hosts Isabella and Elizabeth speak with Elizabeth Kensinger, professor and chair of the Psychology and Neuroscience Department whose research focuses on emotion, memory, and the way positive and negative associations with specific events influence recollection over the course of adulthood. This year, she released her new book, Why We Forget and How to Remember Better, which examines the intricacies of memory encoding and retrieval and memory as an ongoing, active process. Professor Kensinger's work sheds light on aging, cognition, and even how to best study for your next exam.  Tune in to learn about the intersection between sleep and memory, tips for actively retaining information from different events, classes, and study sessions, and even the best way to schedule a daily nap.  Check back in next week for new episodes!

Today's podcast is an interview with Dr. Bernard Robinson. A retired US Army Colonel and long-time HMA member, Dr. Robinson was the Chief of Neurosurgery at Tripler Army Medical Center until 1984, and Chief of the Neuroscience Department with Kaiser Permanente Hawaii Region until 2005.  He continues to work as a neurosurgeon and expert neurosurgical consultant at Tripler, and has authored two books, detailing his journey as a neurosurgeon and on the history of neurosurgery in Hawaii.

Dr. Patrick Simen, an associate professor in the Neuroscience Department at Oberlin College, is back to continue an incredibly fascinating chat about the Brain, A.I., Neural Networks, and Time. Music at the end from Alex the Astronaut with I Think You're Great.

Dr. Irving Biederman Professor of Neuroscience / Department of Psychology / USC (University of Southern California) What is it about the world that attracts us? And why? We talk with Dr. Irving Biederman, whose research probes deep into the human brain to unlock the secrets of our desires to learn new things and to perceive and appreciate the beauty of our world.

Maureen Pisani is a Certified Master Hypnotherapist and the founder of ProThrive Science-Based Hypnotherapy, where she works with individuals and groups (both in-person and online) to help empower, streamline success, and truly thrive. Maureen is also a world-renowned Motivational Speaker and was the Resident Hypnotherapist at the Chopra Center for over 8 years (Carlsbad, CA) until its closure in December 2019. Aside from being a Hypnotherapist, she is also a Master Practitioner of Emotional Freedom Technique (EFT Tapping), Therapeutic Guided Imagery, Neuro-Linguistic Programming (NLP), and Reiki Energy work. She employs a variety of modalities when working with her clients to bring them the best tools and resources for positive and lasting change. Maureen has also been both a Director, Instructor and Mentor at two nationally accredited universities where she shared her love and knowledge of Hypnotherapy with her many students. As of January 2020, she has published 12 books and has co-authored a research paper issued by the Neuroscience Department at UCLA. Maureen Pisani is the poster child for how hypnotherapy can help change your life for the better. After an accident left her in constant pain, she found Hypnotherapy to offer her relief and a new lease on life. Although she now lives in San Diego, CA, Maureen is originally from the Island of Malta and continues to share her love of her home country with all of those she encounters. In her free time, she enjoys dancing, reading, crocheting blankets for premature babies, and gardening. If you’re interested in achieving your goals, please contact Maureen and she’ll be happy to answer your questions. Look for Maureen's episodes https://remarkableresults.biz/?s=Maureen+Pisani (HERE). Website Link: https://prothrivesbh.com (Prothrivesbh.com) Key Talking Points: Unconscious mind- powerful and programmed for what is “safe”Open your unconscious mind to the “what if’s” 2% profit isn’t enough for shops to be successful  Unconscious drive to “stay the same” Self-identity- self-confidence, self-esteem, self-worth, self-respect, self-acceptance and self-love  Business coaches work with the conscious side of the brain but the unconscious mind cannot accept it- Maureen preps the mind to be ready to accept a business coach’s advice in order to get results   Right/left brain/prefrontal cortexRight brain- creative and open to outside the box ideas, that is where hypnosis happens    Everything you do is with intention- hypnosis is only applicable when you are ready for change Change happens gradually- often times you don’t realize it because it becomes a habit  Maureen started hypnotherapy to overcome pain in elbows- had 10 surgeries total Implementing changeLast 30 minutes before you go to sleep you are in a natural hypnotic state Write goals down and every night read them  Self-hypnosis- you have to be aware of what you are doing and be in control  2 types of motivation-moving away from and moving towards. When you are motivated to “move towards” something, the closer you get to it the more motivated you are   Resources: Thanks to Maureen Pisani for her contribution to the aftermarket’s premier podcast. Link to the ‘BOOKS‘ page highlighting all books discussed in the podcast library https://remarkableresults.biz/books/ (HERE). Leaders are readers. Find every podcast episode https://remarkableresults.biz/episodes/ (HERE). Every episode segmented by Series https://remarkableresults.biz/series/ (HERE). Key Word Search https://remarkableresults.biz/tag-cloud/ (HERE). Be socially involved and in touch with the show: http://on.fb.me/1OKap9H (Facebook   )http://bit.ly/1Qn68fO (Twitter   )http://bit.ly/1SVqRvh (Linked In   )Email Listen for free on Apple Podcasts, Google Podcasts, Spreaker, iHeart Radio, Spotify, Podchaser and many more....

Guest, Maureen A Pisani, The Hypnolady,​ Motivational Speaker, Hypnotherapist, Author Maureen Pisani is a Certified Master Hypnotherapist and the founder of ProThrive Science Based Hypnotherapy, where she works with individuals and groups (both in-person and online) to help empower, streamline success and truly thrive. Maureen is also a world renowned Motivational Speaker and was the Resident Hypnotherapist at the Chopra Center for over 8 years (Carlsbad, CA) until its closure in December 2019. Aside from being a Hypnotherapist, she is also a Master Practitioner of Emotional Freedom Technique (EFT Tapping), Therapeutic Guided Imagery, Neuro-Linguistic Programming (NLP), and Reiki Energy work. She employs a variety of modalities when working with her clients to bring them the best tools and resources for positive and lasting change. Maureen has also been both a Director, Instructor and Mentor at two nationally accredited universities where she shared her love and knowledge of Hypnotherapy with her many students. As of January 2020, she has published 12 books and has co-authored a research paper issued by the Neuroscience Department at UCLA.

In this week's interview, Rima talks with Maureen Pisani about her journey in chronic pain and how she has turned that into an opportunity to thrive.   Maureen Pisani is a Certified Master Hypnotherapist and the founder of Pro Thrive Science Based Hypnotherapy, where she works with individuals and groups (both in-person and online) to help empower, streamline success and truly thrive. Maureen is also a world-renowned Motivational Speaker and was the Resident Hypnotherapist at the Chopra Center (Carlsbad, CA) until its closure in December 2019. Aside from being a Hypnotherapist, she is also a Master Practitioner of Emotional Freedom Technique (EFT Tapping), Therapeutic Guided Imagery, Neuro-Linguistic Programming (NLP), and Reiki Energy work. She employs a variety of modalities when working with her clients to bring them the best tools and resources for positive and lasting change. Maureen has also been both a Director, Instructor and Mentor at two nationally accredited universities where she shared her love and knowledge of Hypnotherapy with her many students. As of January 2020, she has published 12 books and has co-authored a research paper issued by the Neuroscience Department at UCLA. Maureen Pisani is the poster child for how hypnotherapy can help change your life for the better. After an accident left her in constant pain, she found Hypnotherapy to offer her relief and a new lease on life. Although she now lives in San Diego, CA, Maureen is originally from the Island of Malta and continues to share her love of her home country with all of those she encounters. In her free time, she enjoys dancing, knitting blankets for premature babies and gardening. If you’re interested in Hypnotherapy, please contact Maureen and she’ll be happy to answer your questions. https://prothrivesbh.com/

This pandemic is a colossal test of our patience - from dealing with family to interminably long wait times on calls with the unemployment office to just wanting this whole nightmare to evaporate so we can go back to the movies. We've got a special, two-part episode this week. In the first part, we bring on a pair of researchers who study patience. The good news: they have found that patience is a quality we can train and develop through meditation and other strategies, including cognitive reappraisal, transcendence, or just learning how to fake it until you make it. (Side note: we also fall into an interesting chat about the benefits of defensive pessimism versus strategic optimism.) After the researchers, we bring on legendary meditation teacher Sharon Salzberg for a deeper dive into how to use meditation to increase our patience, especially when it comes to interpersonal stuff (which, let's be honest, includes other people and ourselves). Our patience experts are Dr. Sarah Schnitker from the Psychology and Neuroscience Department at Baylor University, and Dr. Kate Sweeny from the Psychology department at the University of California, Riverside. Where to find our guests online: Dr. Kate Sweeny / http://www.katesweeny.com/ Dr Sarah A. Schnitker / https://www.baylor.edu/psychologyneuroscience/index.php?id=950614 Sharon Salzberg / https://www.sharonsalzberg.com/ Other Resources Mentioned: Wendy Wood University of Southern California (Habits Research) / https://www.marshall.usc.edu/personnel/wendy-wood Richie Davidson Research on Pain and meditation / https://news.wisc.edu/meditation-expertise-changes-experience-of-pain/ Walter Mischel Marshmellow Test / https://en.wikipedia.org/wiki/Stanford_marshmallow_experiment Additional Resources: Ten Percent Happier Live: https://tenpercent.com/live Coronavirus Sanity Guide: https://www.tenpercent.com/coronavirussanityguide Free App Access for Teachers, Healthcare, Grocery and Food Delivery, and Warehouse Workers: https://tenpercent.com/care Get more focus and clarity by bringing mindfulness to your company with a team subscription to Ten Percent Happier! Visit tenpercent.com/work to learn more. Full Shownotes: https://www.tenpercent.com/podcast-episode/patience-246

In this podcast, Tina Persson, the founder of PhD Career Stories has an interesting interview with Dr. Laura Pozzi, who is currently working as a Scientific Writer for a Swedish Biotech, Atlas Antibodies, in Stockholm. Her role involves content creation and scientific marketing communication. Laura received her Ph.D. in Life and Biomolecular Science at the IRCSS-Mario Negri Institute for Pharmacological Research, Milan in 2011.  After her graduation, she joined the Neuroscience Department at Karolinska Institute in Stockholm, where she worked as a postdoc until 2017. Her research interest focused on the identification of the molecular aspects of brain disorders. If you are curious about how Laura stepped out of academia and started a new career, please listen to this episode. If you also have a story to be told or if you know someone, please don’t hesitate to contact us. Enjoy Listening!

The early years of human development needs to be an essential priority for the whole community and by creating awareness of the importance of the early years in children's development, communities can help create and implement an action plan specific to enhancing healthy childhood development. One essential element for children's development is play. Play allows children to use their creativity while developing their imagination and physical, cognitive, and emotional strength. It is through play that children at a very early age learn to engage and interact with the world around them. The importance of play in childhood development is what brought Lethbridge Early Years Coalition to spearhead the development of the Lethbridge Play Charter for all children ages 0 - 18. This Play Charter was adopted by the City of Lethbridge as a unifying document that influences planning, policy and decision making in our community. Organizations, agencies, and community members are committed to prioritizing and promoting the importance of play. The speaker will present on why play is essential for healthy human development, explore some of the reasons why play has changed and how we as a community can work together to prioritize play. Speaker: Vicki Hazelwood Vicki Hazelwood, Coordinator of Lethbridge Early Years Coalition (LEYC), is passionate about children having a great start in life and fostering healthy families. Vicki also works as Coordinator for Building Brains Together, which is a “play project” out of the Neuroscience Department at the University of Lethbridge. Vicki has been supporting families through teaching, facilitating, and speaking on the topic of early childhood development and parenting for over 15 years. Moderator: Chelsea Sherbut Date: Thursday, February 13, 2020 Time: Doors open 11:30 am, presentation 12 noon, buffet lunch 12:30 pm, Q&A 1 – 1:30 pm Location: Royal Canadian Legion (please enter at north door) 324 Mayor Magrath Dr. S. Lethbridge Cost: $14 buffet lunch with dessert/coffee/tea/juice or $2 coffee/tea/juice. RSVP not required

The early years of human development needs to be an essential priority for the whole community and by creating awareness of the importance of the early years in children's development, communities can help create and implement an action plan specific to enhancing healthy childhood development. One essential element for children's development is play. Play allows children to use their creativity while developing their imagination and physical, cognitive, and emotional strength. It is through play that children at a very early age learn to engage and interact with the world around them. The importance of play in childhood development is what brought Lethbridge Early Years Coalition to spearhead the development of the Lethbridge Play Charter for all children ages 0 - 18. This Play Charter was adopted by the City of Lethbridge as a unifying document that influences planning, policy and decision making in our community. Organizations, agencies, and community members are committed to prioritizing and promoting the importance of play. The speaker will present on why play is essential for healthy human development, explore some of the reasons why play has changed and how we as a community can work together to prioritize play. Speaker: Vicki Hazelwood Vicki Hazelwood, Coordinator of Lethbridge Early Years Coalition (LEYC), is passionate about children having a great start in life and fostering healthy families. Vicki also works as Coordinator for Building Brains Together, which is a “play project” out of the Neuroscience Department at the University of Lethbridge. Vicki has been supporting families through teaching, facilitating, and speaking on the topic of early childhood development and parenting for over 15 years. Moderator: Chelsea Sherbut Date: Thursday, February 13, 2020 Time: Doors open 11:30 am, presentation 12 noon, buffet lunch 12:30 pm, Q&A 1 – 1:30 pm Location: Royal Canadian Legion (please enter at north door) 324 Mayor Magrath Dr. S. Lethbridge Cost: $14 buffet lunch with dessert/coffee/tea/juice or $2 coffee/tea/juice. RSVP not required

The early years of human development needs to be an essential priority for the whole community and by creating awareness of the importance of the early years in children's development, communities can help create and implement an action plan specific to enhancing healthy childhood development. One essential element for children's development is play. Play allows children to use their creativity while developing their imagination and physical, cognitive, and emotional strength. It is through play that children at a very early age learn to engage and interact with the world around them. The importance of play in childhood development is what brought Lethbridge Early Years Coalition to spearhead the development of the Lethbridge Play Charter for all children ages 0 - 18. This Play Charter was adopted by the City of Lethbridge as a unifying document that influences planning, policy and decision making in our community. Organizations, agencies, and community members are committed to prioritizing and promoting the importance of play. The speaker will present on why play is essential for healthy human development, explore some of the reasons why play has changed and how we as a community can work together to prioritize play. Speaker: Vicki Hazelwood Vicki Hazelwood, Coordinator of Lethbridge Early Years Coalition (LEYC), is passionate about children having a great start in life and fostering healthy families. Vicki also works as Coordinator for Building Brains Together, which is a “play project” out of the Neuroscience Department at the University of Lethbridge. Vicki has been supporting families through teaching, facilitating, and speaking on the topic of early childhood development and parenting for over 15 years. Moderator: Chelsea Sherbut Date: Thursday, February 13, 2020 Time: Doors open 11:30 am, presentation 12 noon, buffet lunch 12:30 pm, Q&A 1 – 1:30 pm Location: Royal Canadian Legion (please enter at north door) 324 Mayor Magrath Dr. S. Lethbridge Cost: $14 buffet lunch with dessert/coffee/tea/juice or $2 coffee/tea/juice. RSVP not required

Join Tim Ray and his guest Maureen A Pisani. Originally from the Island of Malta, Maureen has been through several chapters of life. As an Author and Motivational Speaker, she utilizes her experiences to highlight how each of us has hidden strengths within us. As a Hypnotherapist, Maureen is at the Mastery Level in all 4 modalities – Hypnotherapy, Therapeutic Guided Imagery, Neuro-Linguistic Programming (NLP), and Reiki Energy work and teaches the first three. In addition, she is the ONLY Hypnotherapist who has been a Director and Instructor in two Nationally Accredited Colleges and is also a Trainer for NLP. Because of her medical and scientific training and background, she is also the ONLY Hypnotherapist who is a co-author of a research paper issued by the Neuroscience Department at UCLA. She is the resident Hypnotherapist at the renowned Chopra Center in La Costa, San Diego County, CA. Maureen has authored 10 Hypnotherapy books and produced over 25 Hypnotic CDs. She is the founder of Pro-Thrive Science-Based Hypnotherapy where she works with groups and individuals, to help them go from just surviving to truly thriving. http://maureenpisani.com/

In this interview with Natural Medicine Journal's publisher, Deborah Yurgelun-Todd, PhD, and Perry Renshaw, MD, PhD, MBA, discuss the research they are conducting at The University of Utah in the Neuroscience Department. They specifically describe research associated with the safety and efficacy of supplemental citicoline, as well as evaluate emerging research in this area. Approximate listening time: 30 minutes About the Experts Deborah Yurgelun-Todd, PhD, is director of the Neuroscience Initiative and a USTAR Professor of Psychiatry at the University of Utah School of Medicine. Her research focus is on identifying the neuropsychological and neurobiological bases of human behavior. Yurgelun-Todd is an expert in the application of structural and functional magnetic resonance imaging, the administration and analysis of neurocognitive tests, and the integration of the results obtained by these multiple modalities. She has examined the etiologic bases of neural models of dysfunction in psychiatric disorders including depression, bipolar illness, substance misuse, and schizophrenia. She is also recognized for applying imaging techniques to study cortical changes during development in healthy children and adolescents, and during treatment intervention in adult patients.   Perry Renshaw, MD, PhD, MBA, is a USTAR Professor of Psychiatry at the University of Utah School of Medicine and a Medical Director of the VISN 19 Mental Illness Research, Education and Clinical Center (MIRECC) at the Salt Lake City Veterans Affairs Medical Center. His training as a biophysicist and psychiatrist has led to a primary research interest in the use of multinuclear magnetic resonance spectroscopy (MRS) neuroimaging to identify changes in brain chemistry associated with psychiatric disorders and substance abuse. Current clinical trials are focused on the use of citicoline as a treatment for methamphetamine dependence, creatine as a treatment for depression, and uridine as a treatment for bipolar disorder. Renshaw’s recent work focuses on brain chemistry changes that may increase depression and suicide for people living at high altitudes. Transcript  Karolyn Gazella: Hello, I'm Karolyn Gazella, the publisher of the Natural Medicine Journal. Today, I'm thrilled to be joined by two highly respected brain researchers from them University of Utah Neuroscience Department, Dr. Deborah Yurgelun-Todd and Dr. Perry Renshaw. Now, before we begin and dig into today's topic, I'd like to have each of you describe the focus of your research. So let's start with you, Dr. Yurgelun-Todd. Deborah Yurgelun-Todd: Yeah. Well, my research is initially started to focus on cognitive function and the neuropsychological, or brain, pathways that mediate how we think and how we feel. And then I became very interested in the application of brain-imaging to help us understand exactly how those pathways worked and give us some insights into how the brain does things well, and how it does things less well. Gazella: Perfect. Now, Dr. Renshaw, how about you? Can you please describe your research focus? Renshaw: Well, sure. Well, I'm sort of confused soul. I'm a psychiatrist/biophysicist, and the way in which I merged these techniques together is to do brain-imaging studies that focus on, how is brain chemistry altered in, particularly, diseased states that psychiatrists might be interested in. And based on identifying unusual patterns in brain chemistry, my research group likes to focus on identification and development of novel treatment strategies. One of which is a molecule, I guess we'll be talking about today, CDP-choline or Cognizin. Gazella: Perfect. And you're absolutely correct, I'd like to talk about citicoline in a lot more detail. Now, Dr. Yurgelun-Todd, why did you become interested in citicoline for the brain, and why did it catch your attention? Yurgelun-Todd: Well, they've done some work looking at why the brain was not working very well in mood disorders, and why attention, in particular, was a problem in individuals who had depression and other mood disorders. And when citicoline was brought to my attention, there seemed to be interesting potential for that to alter attentional systems. So I became very excited at the possibility of that becoming a treatment for individuals who may not have optimal brain functioning. Gazella: Perfect. I love the fact that attention actually is what caught your attention, so that's brilliant. That's brilliant. Now, Dr. Renshaw, what does the scientific literature tell us about the safety of citicoline, and are there any contrary indications or risks associated with its use orally? Renshaw: You know, that's a great question because we have a really well established answer that citicoline has been used millions of times around the world. In some countries, particularly where they use it as an intravenous administration as a drug. In other countries like the US and Canada, it's a nutritional supplement. We've done studies, or rather, Dr. Yurgelun-Todd has done studies looking at the effects of citicoline on adolescents and she can describe what she saw. But, by and large, you have to take a whole lot of citicoline before you notice anything adverse. And in the few instances where we've seen that, it's been people feeling like they've had too much Starbucks coffee and that goes away over about a half an hour. Gazella: Yeah, and I would like to hear about the studies on children, Dr. Yurgelun-Todd. What does your research tell you about safety, especially in that population? Yurgelun-Todd: It's very interesting because we, as I mentioned, I was interested in potential ways to improve thinking and so we decided we would look at the developing brain in individuals who were adolescent. And we found that when we supplemented with citicoline, they actually improved their attentional span and could do—and had some improvement in their psychomotor function as well. So this was in healthy adolescence, rather than anyone who actually had a documented impairment. The fact that you could see improvement in cognitive functioning and psychomotor functioning in healthy individuals without a documented impairment was actually quite remarkable. The other thing that was remarkable was that the dosing was very low, and in fact, this was a new area to explore. How low could we dose and still see an effect on the brain? So we were quite enthusiastic about those finding and think they have important implications. With regard to safety, we also were very rigorous in the documenting potential side effects associated with the administration of citicoline and we really saw essentially no side effects in the side effects profile that we did document. Looked very similar to the placebo, in fact, was not statistically different between placebo and the treatment arm. So we were really reassured that even with the rigorous assessment for side effects, there was nothing that was documented in this trial. What's really compelling, however, is that most treatments for cognitive changes or for any neurologic disorder, neuropsychiatric disorder do end up having side affect issues, some of them being more visceral, like stomach or headache or things like that, but also some of them actually diminishing your cognitive functioning. So this was rather remarkable that we could enhance cognitive functioning with no side effects. Gazella: Yeah. I mean, it's good to hear that the safety profile is good. And I may want to come back on that topic of children, but Dr. Yurgelun-Todd, I'm going to stick with you here. There's a wide variety of brain functions and cognitive issues that have been researched associated with the use of citicoline, like focus, attention, dementia, and other issues. Which area, presently, has the strongest, and most compelling research? Yurgelun-Todd: Well, that's a very interesting question because there's a biased based on what science you happen to love. I think some of the most compelling research has been associated with the fact that there's a repair mechanism associated with the administration of citicoline, that is, cellular biochemistry is actually altered and phospholipid synthesis is improved when you have an administration of citicoline, therefore, individuals who have neurological insults, such as strokes or mild traumatic brain injury, things like that can see rapid repair in their cells with citicoline administration. That is the area that's more involved in the patient or the real neurological insult area. Within the healthy individual, I think the most compelling research really falls on two ends of the lifespan, that is the elderly or middle-age and above, and also then some of the work we talked about in adolescence, where both when your brain is growing rapidly and also when your brain is aging, it seems as if the supplement with Citicoline can make a substantial difference. Gazella: Yeah, that's interesting. Now, Dr. Renshaw, there's preliminary research demonstrating that citicoline may be able to help with cocaine dependence and addictions. I find that pretty fascinating. How promising is that research, and do you see that as a viable application in the future? Renshaw: Yeah. No, that's a great question. Citicoline, broadly speaking, has 2 effects. One that Dr. Yurgelun-Todd just touched on. Brain repairs is probably more well established and been investigated for probably 30 or 40 years. Our work, to a first approximation, looks at the effects of citicoline in terms of increasing the levels, brain levels, of neurotransmitters, particularly dopamine and norepinephrine in the brain. When someone is using cocaine or methamphetamine, they often have a depletion of dopamine within their brain, as well as, in the case of methamphetamine, some damage related to decreases in blood flow. From that perspective, citicoline is almost a perfect fit in terms of what it can do an active user, increasing the level of dopamine in the brain, makes them feel, I think, more intact and, perhaps, less inclined to continue using drugs. And the brain repair mechanism because the mechanism on which stimulants cause brain damage is often related to ischemia. It's just a really good fit. Where we're going now in this research, is that we've broadened our scope from cocaine to methamphetamine to stimulants that are used to treat ADHD. In fact, we are in the middle of finding a study supported by the National Institutes on Drug Abuse, we're working with in Salt Lake City and Seoul, South Korea. And what we're looking at is adolescents who are using stimulants, not necessarily as a drug of abuse, as a way to approve their attention, focus, and do better on very rigorous South Korean college entrance exams. Some estimates suggest that close to a quarter of all high school students in South Korea are taking stimulants, which is probably not good or the long-term outcome of which is not good. We think citicoline may be a way to help people feel better and get off the use of stimulants. Which is better avoided, unless you have a really good reason for continuing treatment with that class of medication. Gazella: Yeah. That's actually one of the questions I was going to ask. When you're talking about using citicoline in healthy children, I was curious ... and Dr. Renshaw, I'll stick with you on this one ... I was curious, I have not read any studies using citicoline for children with ADHD, but I think what you're saying is you're evaluating whether or not this could be a viable alternative to the pharmaceuticals that are being used for ADHD. Is that what I'm hearing? Renshaw: There's a real divide, at least in the United States, between things that are approved as natural products, nutritional supplements, and pharmaceutical agents. The natural product industry lives in fear of having their products considered to be drugs because the amount of testing, and safety monitoring, and efficacy, and evaluation that goes into getting something onto the market as a drug is really very expensive and onerous. So for us, any research that we do, we have to have it paid for itself. It's been a lot easier to look at the use of citicoline in healthy populations, and certainly the sponsors of the work that we've done, which have been certain large natural product companies, who are much, much happier without us in approach. That's said, if I take off my sort of business man's hat and put on the scientific garb, what we believe is that, in fact, citicoline would likely have good effects for treating ADHD. In Europe, it's been used as a drug to treat Parkinson's disease with good outcomes, and Parkinson's disease is, as you may know, is also a disorder associated with decreased dopamine in the brain. The ability to increase focus and attention is generally quite good. The difference between citicoline and the stimulant per se, is the effect of citicoline is to increase the brain's concentration of dopamine, that you're encouraging the brain to make dopamine when it otherwise might not do so. Stimulants just release dopamine from the brain and tend to deplete it, so they are very different mechanisms, and there's every reason to think that they'd both be affective. They probably have different safety profiles. Gazella: That's fascinating. And Dr. Renshaw, I'm going to stay with you one more time. What about autism, autism spectrum? There's numerous conditions that are in that category. Any preliminary research in that or are we pretty much leaving that alone for now? Renshaw: We haven't been involved in that research. There was a company we did some research with in the Boston area, that was very interested in a related compound from the treatment of autism. They got involved in a big patent dispute with the University of California in San Diego that was resolved in UCSD's favor. So I don't think there's ever been a trial. But, there certainly is a suggestion in the autism literature to treat with pyrimidines, as the effect of either cytidine or uridine on the brain might help some individuals with autism spectrum disorders, but I think in fairness, it's really quite preliminary and that we'd have to do studies to understand what the effects were likely to really be to a population. Gazella: Yeah. That makes a lot of sense. Now, Dr. Yurgelun-Todd, I'd like to stay on this topic of exciting new research in the area of citicoline use. Another area of research that's pretty interesting, and could be significant, is the use of citicoline for appetite control. I mean, obviously we have an issue with obesity in this country. Is it too early to tell is this may be a promising application of citicoline in the future? Yurgelun-Todd: You know, I don't think it is. We've noticed some years ago that in looking at the response to food cues, individuals who had received the supplementation of citicoline actually showed significant decreases in appetite and that this was related to dose of citicoline that they'd received. And the thing that was interesting about that data, was it wasn't just that the individual said, "Oh, I feel like I have a reduced appetite." They actually showed differences in the way their brain responded to the cues, such as food items, ice cream, donuts, things like that when they viewed them in the magnet. So we had documentation that neural activation was altered in food-processing related areas of the brain, as well as having a decrease in appetite, which really suggests that there is some mediation of brain responses to appetitive cues, which is really one of the problems with obesity. And within weight control, that's just sort of having an over-reaction to these kinds of cues. And thinking about it further, it didn't really surprise us because it goes back to what Dr. Renshaw just mentioned about the dopamine system, the dopamine system in addiction are part of the reward system in the brain and the ... although we initially focused on the impact of citicoline on cellular function and phospholipid metabolism, we recognized as we thought about it further, that the concentration of dopamine is being changed with the supplementation of citicoline as well. So we're changing neurotransmitter balance in the brain and that had a really positive affect in terms of response to food items. I don't know if Dr. Renshaw wants to comment. Renshaw: No, I think that's right. When stimulants have been used for this purpose, in fact, that's why many of them were developed initially, but they sort of force the brain to release all the dopamine that it's already made. What we really like about citicoline or pyrimidines as a strategy for increasing brain dopamine is that A, it's really encouraging the brain to speed up synthesis, which is sort of what you'd like to do, and again from a safety perspective the latter approach should be much safer for individuals taking a supplement or another medication over time. Yurgelun-Todd: To go back to your question on is it too soon. I don't think so because I think most studies that we hear about are really just using self-report and don't have the documentation of a brain response. You couldn't really fake a brain response in terms of metabolic activations, so that is a really, I think, robust piece of research that will support this as an appetite moderator. Gazella: That's fascinating. Now, I want to stick with you, Dr. Yurgelun-Todd because I do want to go into dosage. But specific to appetite control, what was the dosage used? Yurgelun-Todd: 2,000 milligrams in the study that we did. Although, we did not ... we've not had the opportunity to see how low we can go to have this effect. And this was in middle-aged individuals. So we were looking at people, 40 to 60 years old, and they were looking at the extent to which having a 6-week supplementation could impact the brain. And that's what we saw. Gazella: And 2,000 milligrams, is that divided doses? Yurgelun-Todd: Yes, it was. It was morning and evening. Gazella: Okay, perfect. Now, Dr. Renshaw, I want to dig a little bit deeper into this issue of dose. Now, does the dose of citicoline vary depending on the application or is there a consistent dosage range that is affective across most conditions? Renshaw: That's a great question, and citicoline has a funny history that was used most extensively first in Europe. And there, after an injection of citicoline, they had a lot of trouble showing that there was any citicoline or cytidine in the bloodstream. When they went to oral ingestion, that became an even bigger problem. And it turns out, that the stomach plays tricks with citicoline, it turns the cytidine, that's part of it, into a molecule called uridine, which is the predominate pyrimidine in the human central nervous system. Because of that, it's been a wide spectrum on the views on how bioavailable, that is how much citicoline gets used by the body. It turns out that if you measure uridine, essentially all the citicoline is absorbed and gets distributed across the body, but it took a long time to figure that out. This was sorted out by a scientist at MIT, Richard Berkman, who's also studied citicoline extensively. If you look at the clinical indications, a lot of the ones we look at, mood disorders, attention-deficit disorder, probably require lower doses. In the United States, the most recent trials have really looked at serious brain injury conditions, like stroke, and so there have been trials that are conducted with oral administration of citicoline to treat stroke. The problem there is that in the context of someone who's found out a real metabolic stress affecting the brain and the body, it just sort of absorbs things effectively from your stomach, plus you've got a problem with the area you want to impact has got decreased blood supply due to the stroke. And doses went up to something like four grams a day in those instances. We've been ... most of our indications using somewhere between 500 and 2,000 milligrams of citicoline. The effects of citicoline last for about two, or three, or four hours just depending on the individual. So taking it twice a day works reasonably well. There is, for many normal people, a self-correcting mechanism, which if you're taking more than your body needs, you will feel anxious and jittery. That's relatively uncommon. Anyone taking less than 2,000 milligrams a day is unlikely to have side effects. This is obviously important in figuring out what to do. Studies in children, for example, as Dr. Yurgelun-Todd has done. Children come in a variety of shapes, sizes, and weights. It's probably going to be important to adjust the dose to reflect the weight of the child. Gazella: Yeah. I think one of the fascinating things for me with citicoline, is that it does, in fact, have efficacy at what could be considered a fairly low dose, even as low as 250 milligrams. But even at 500 milligrams, that's a pretty low dose, and it's still showing affect, correct? Renshaw: That's right. From that perspective, it's really important to recognize that one of the most established effects of citicoline is to speed up membrane synthesis, and this is true in every cell in the body, and we all travel around with CDP-choline in our cells. For that reason, because it's highly important in controlling this fundamental process, the body tends to keep the concentration of CDP-choline low. So that relatively low doses, especially for natural product, work much more effectively than is true of almost any other type of natural product. And again, we think that that has a lot to do with the fact that it's a really important regulatory control molecule within the body. Gazella: Right. Now, Dr. Yurgelun-Todd, we've talked about a lot of different conditions, and application, and some pretty exciting emerging research associated with the oral use of citicoline. Out of all of that, what do you feel shows the most promise? Yurgelun-Todd: I think I'm going to relate that to where I think there's a great deal of need. And that is in our children, and our adolescents, and young adults. And specifically, I think the fact that we can provide a very safe, minimally, essentially no side effect treatment to improve attention, and you touched on this earlier, I think is very significant. We've not done studies in ADHD or populations, such as a diagnosed ADHD population, but I'm quite sure that this would be a supplement that would make a significant difference for many of those and not have any long-term or short-term side effects. So I think that's a very important point. The other thing that hasn't been as well explored, but I think is important, is the area of concussion or sports injury. Where, I believe, because of the data that we've seen in stroke, and in other neurologic disorders there's every reason to believe that citicoline could actually provide a preventative capacity, like in a sports drink or a bar, something to that effect, prior to concussion. And then also supplementation during the season could be very helpful. So I think that ... well, that hasn't been an area that we've focused on so much. I think given the attention now in the sports of our children and college students, that this would be an area that could be really important. And then, of course, my original reason for wanting to get into this work, which is mood disorders. I think that we hadn't really capitalized on the impact of Cognizin on improving mood disorders. And I think there are many individual, particularly, in the perimenopausal age group who have found that this has been a very important supplement in their life and has helped them significantly in feeling that they can think more clearly and feel better overall. So those are my favorite areas to think about. Gazella: Yeah. That concussion, that is really fascinating and it would be great if there could be some studies done there. Dr Renshaw, do you agree? Anything to add to that list? Renshaw: Yeah. There's a substance abuse investigator at the University of Texas Southwestern in Dallas, Sherwood Brown, who did a study of the individuals who had both, cocaine dependence and bipolar disorder. And what he found was citicoline was actually much more effective in treating the bipolar disorder than the cocaine dependence in the patients that he was working with. We have a colleague here in Utah, Doug Hondo, who looked at that and said, "Why would something like citicoline be effective in treating bipolar disorder?" And he's developed a theory that suggests that citicoline may have a really potent antisuicidal effect. And it shares, to an unbelievable degree, many of the same effects on the human brain that both lithium, which is known to antisuicidal and ketamine, which is the antidepressant for those of us in psychiatry. So he's about to begin a study looking at whether or not, and this has been funded by the Veterans Administration, Citicoline reduces suicidality with treatment for only the first week. This is very exciting, and is something that will get underway, it's a 4-year study, in a couple of weeks. And if that's really true, and you could get the same protective effect without having to take Lithium or Ketamine, both of which have pretty significant side effects, that would be a real advance. The compound that Doug will be using in the study is uridine, which is the major metabolite that citicoline provides through the body in [inaudible 00:25:19]. Gazella: Dr. Yurgelun-Todd, because we're talking about bi-polar mood disorders, a lot of these folks are on some heavy duty medications as Dr. Renshaw just mentioned. Do we know anything about interactions? I don't know that there's been any studies, but if somebody is on a Prozac, or an antidepressant, or some of these other, Lithium and whatnot, can citicoline be taken with that or is that a no-no? Yurgelun-Todd: Thus far, I don't know of a clinical trial that examined that specific question, however, everything that we know about citicoline would suggest that because this is found in normal diets and is a part of the human body, that it would not have any interaction effect with the treatments that have been provided. So it should be perfectly safe. Gazella: Yeah. That makes some logical sense. Yurgelun-Todd: But with the caveat that we don't have that empirical data. Gazella: Right. You're basing that on logic and mechanisms of action and ... Yurgelun-Todd: Exactly. Gazella: Now, Dr. Renshaw, I'm going to put you on the spot here, but this is your area of expertise, your background is with addiction. I would love to hear your thoughts on our present opioid epidemic. I realize that this is a huge topic. This might be an unfair question, but can you give us a snapshot from your perspective as a researcher with this type of expertise, what needs to happen to get this issue, this opioid epidemic under control? Renshaw: Boy, if I knew the answer to that question, I'd have a really high profile job. We're very interested in addiction as you know, we live in the Rocky Mountain states, and so one of the things we study is, what happens when someone moves from a lower altitude to higher altitude, and what we find is that people often get more depressed and more anxious and, curiously, use more different kinds of drugs of abuse. So I guess you could say, flatten out the Rocky Mountains states, but that's not actually our strategy. We're looking for molecules like citicoline that may have an effect in changing brain chemistry in ways that are effective in treating some of these high altitude related conditions. The fact that this is something you can do that changes the use of drugs across a broad variety of categories suggests that these may be molecules that are really valuable in treating a range of different addictive disorders, but clearly you've figured out by now, that I'm sort of waving my hands because I think there are a lot of very smart people who are struggling with the question of how do you prove the problems of opiate dependence in this country. And it's really shocking how we have a problem that's occurred over a short period of time. Gazella: Right. We've covered it in the Natural Medicine Journal, so it's definitely in our radar as well. Now, I think we covered everything, but Dr. Yurgelun-Todd, is there any final thoughts that you'd like to add on this subject? Yurgelun-Todd: Yeah, just one final thought, which is that I think that the impact of citicoline and particularly Cognizin citicoline has not been fully appreciated yet. It's come a long way since we began working with it and I think we've appreciated that it has multiple types of impact on the human brain and body, but I think we have even more potential to see it improve the quality of our lives. So I'm excited to continue working with it. Gazella: Yeah. That's kind of why I wanted to focus on the emerging research because I think that that's very exciting, and I think that this can be a really positive clinical tool for healthcare practitioners. Dr. Renshaw, anything else to add to that? Renshaw: Just one comment and then a tantalizing tidbit if you will, we can edit this out, I guess. But one of the things that we think is going be an important trend, is the combination of citicoline with other natural products as a way to boost its efficacy. And that's something that hasn't happened yet, but we have some combinations that we're exploring now. One of the things that Dr. Yurgelun-Todd didn't share with you, is she has, across 3 different studies, evidence that citicoline also improves complexion. It has effects on skin tone, which makes some sense when you think that both the brain and the skin are rapidly turning over cells. So that's an area that's a little bit outside our area of clinical expertise that merits investigation as well. Gazella: Wow. Yeah, that is pretty interesting because that could then ... it could be a topical ingredient. Yurgelun-Todd: Right. Exactly. Renshaw: Exactly. Gazella: Yeah. Wow. That's pretty interesting. Well, I want to thank you both for joining me. This has been fascinating and information-packed. I'm so pleased that you took time out of your schedule to join me today. And I hope you have an awesome day. Yurgelun-Todd: Well, thank you so much. We were delighted to join you. Renshaw: Yeah, you too, Karolyn.

Maureen Pisani is a mega Brain! https://prothrivesbh.com Originally from the Island of Malta, Maureen has been through several chapters of life.  As an Author and Motivational Speaker, she utilizes her experiences to highlight how each of us has hidden strengths within us.  As a Hypnotherapist, Maureen is at the Mastery Level in all 4 modalities – Hypnotherapy, Therapeutic Guided Imagery, Neuro-Linguistic Programming (NLP), and Reiki Energy work.  In addition, she is the ONLY Hypnotherapist who has been a Director and Instructor in two Nationally Accredited Colleges and is also a Trainer for NLP.  Because of her medical and scientific training and background, she is also the ONLY Hypnotherapist who is a co-author of a research paper issued by the Neuroscience Department at UCLA.  She is the resident Hypnotherapist at the renowned Chopra Center in La Costa, San Diego County, CA. Maureen has authored 9 Hypnotherapy books and produced over 25 Hypnotic CDs.                

Alfonso Abizaid, Ph.D., talks about the problems associated with dieting; identifies hormonal mechanisms associated with the generation of appetite; and discusses how these hormones affect hypothalamic and extra-hypothalamic feeding circuits to increase the motivation to eat under normal and during stressful situations. Dr. Abizaid is now a tenured professor at the Neuroscience Department at Carleton University. To learn more about Robard, visit www.robard.com.

Our understanding of brain development and function has fundamentally changed in the past decade. Brain development embody much more than just the simple unfolding of a genetic blueprint but rather represents a complex dance of genetic and environmental events that interact to adapt the brain to fit a particular environmental context. Thus, it is now clear that prenatal, postnatal and early childhood experiences set the brain on a trajectory that profoundly influences not only how children learn and develop but also contribute to health and wellness throughout the lifespan. The speaker will expand on this fascinating topic and also very briefly touch upon the possible effects common drugs and injuries (concussions) may have on the brain. Speaker: Dr. Bryan Kolb A native of Calgary, Bryan Kolb has been professor at the University of Lethbridge for 37 years and was the co-founder of their Neuroscience Department. He has published five books, including two textbooks with Ian Whishaw and roughly 350 articles and chapters. Bryan Kolb was awarded a Killam Fellowship from the Canada Council and is a Fellow of the Royal Society of Canada. He is a former President of the Canadian Society for Brain, Behavior and Cognitive Science and of the Experimental Division of the Canadian Psychological Association. Kolb is currently a Senior Fellow of the Canadian Institute for Advanced Research's program on Child Brain Development. His recent work has focused on how neurons of the cerebral cortex change in response to various factors including hormones, experience, drugs, neurotrophins, and injury, and how these changes are related to behaviour.

Our understanding of brain development and function has fundamentally changed in the past decade. Brain development embody much more than just the simple unfolding of a genetic blueprint but rather represents a complex dance of genetic and environmental events that interact to adapt the brain to fit a particular environmental context. Thus, it is now clear that prenatal, postnatal and early childhood experiences set the brain on a trajectory that profoundly influences not only how children learn and develop but also contribute to health and wellness throughout the lifespan. The speaker will expand on this fascinating topic and also very briefly touch upon the possible effects common drugs and injuries (concussions) may have on the brain. Speaker: Dr. Bryan Kolb A native of Calgary, Bryan Kolb has been professor at the University of Lethbridge for 37 years and was the co-founder of their Neuroscience Department. He has published five books, including two textbooks with Ian Whishaw and roughly 350 articles and chapters. Bryan Kolb was awarded a Killam Fellowship from the Canada Council and is a Fellow of the Royal Society of Canada. He is a former President of the Canadian Society for Brain, Behavior and Cognitive Science and of the Experimental Division of the Canadian Psychological Association. Kolb is currently a Senior Fellow of the Canadian Institute for Advanced Research's program on Child Brain Development. His recent work has focused on how neurons of the cerebral cortex change in response to various factors including hormones, experience, drugs, neurotrophins, and injury, and how these changes are related to behaviour.

Our understanding of brain development and function has fundamentally changed in the past decade. Brain development embody much more than just the simple unfolding of a genetic blueprint but rather represents a complex dance of genetic and environmental events that interact to adapt the brain to fit a particular environmental context. Thus, it is now clear that prenatal, postnatal and early childhood experiences set the brain on a trajectory that profoundly influences not only how children learn and develop but also contribute to health and wellness throughout the lifespan. The speaker will expand on this fascinating topic and also very briefly touch upon the possible effects common drugs and injuries (concussions) may have on the brain. Speaker: Dr. Bryan Kolb A native of Calgary, Bryan Kolb has been professor at the University of Lethbridge for 37 years and was the co-founder of their Neuroscience Department. He has published five books, including two textbooks with Ian Whishaw and roughly 350 articles and chapters. Bryan Kolb was awarded a Killam Fellowship from the Canada Council and is a Fellow of the Royal Society of Canada. He is a former President of the Canadian Society for Brain, Behavior and Cognitive Science and of the Experimental Division of the Canadian Psychological Association. Kolb is currently a Senior Fellow of the Canadian Institute for Advanced Research's program on Child Brain Development. His recent work has focused on how neurons of the cerebral cortex change in response to various factors including hormones, experience, drugs, neurotrophins, and injury, and how these changes are related to behaviour.

Our understanding of brain development and function has fundamentally changed in the past decade. Brain development embody much more than just the simple unfolding of a genetic blueprint but rather represents a complex dance of genetic and environmental events that interact to adapt the brain to fit a particular environmental context. Thus, it is now clear that prenatal, postnatal and early childhood experiences set the brain on a trajectory that profoundly influences not only how children learn and develop but also contribute to health and wellness throughout the lifespan. The speaker will expand on this fascinating topic and also very briefly touch upon the possible effects common drugs and injuries (concussions) may have on the brain. Speaker: Dr. Bryan Kolb A native of Calgary, Bryan Kolb has been professor at the University of Lethbridge for 37 years and was the co-founder of their Neuroscience Department. He has published five books, including two textbooks with Ian Whishaw and roughly 350 articles and chapters. Bryan Kolb was awarded a Killam Fellowship from the Canada Council and is a Fellow of the Royal Society of Canada. He is a former President of the Canadian Society for Brain, Behavior and Cognitive Science and of the Experimental Division of the Canadian Psychological Association. Kolb is currently a Senior Fellow of the Canadian Institute for Advanced Research's program on Child Brain Development. His recent work has focused on how neurons of the cerebral cortex change in response to various factors including hormones, experience, drugs, neurotrophins, and injury, and how these changes are related to behaviour.

Please click on the POD button to listen to the latest Atlanta Business Radio  show podcast broadcasting live each Wednesday at 10am EDT from Atlanta, GA, USA.   Atlanta Business Radio is sponsored by Fast Pitch! Networking - a one-stop shop for networking and marketing your business online and offline. Please go to their website www.fastpitchnetworking.com. When you sign up, please mention you were referred by Lee Kantor. That will help the show! Thanks. By the way Amy and I have our first Atlanta Fast Pitch Networking Event of 2008 at McCormick & Schmick's Seafood Restaurant - Dunwoody on January 16 2008 from 5pm-7pm. RSVP by CLICKING HEREHere's how to listen to the podcast of our show. First click on the title of the show you are interested in. Then there should be a player in the upper right hand corner of the screen. Now just press play and the show you chose should start playing. You can also download the show to listen on your mp3 player. We are now available on iTunes, click this link and you can find all our past shows. Press SUBSCRIBE and you will automatically get the latest show when you sync your iPod to your computer.Remember if you want a pretty comprehensive listing of all kinds of Atlanta Events including Business Networking events please check out www.AtlantaEvent.com.  This morning we talked about all things Taste of Dunwoody. Taste of Dunwoody is an event that is close to the heart of Amy as she has been involved with it since it started. The event benefits Children's Healthcare of Atlanta every year and this year donations will go to the Department of Neuroscience. So we started the show with Dr Tom Burns one of the Directors in the Neuroscience Department who shared lots of great information about all the good that Children's is doing to help kids in Atlanta and the Southeast. As Children's is a not for profit hospital they are constantly raising funds in order to do help more kids. They spend a lot of the money on technology and research. Four areas they work in are: NeuroTrauma, NeuroOncology, NeuroSpine and Epilepsy. For more information please go to their website www.choa.org.Next we had on Pam Koch, the co-chair of the Taste of Dunwoody event. She told us the event takes place February 1 from 7pm - 10:30pm. It will be at the W Hotel in Dunwoody and will feature almost 3 dozen of the areas best restaurants sampling some of their favorite dishes. For a small donation you get to go nuts and try food from restaurants like: Alons, Brooklyn Cafe, Wildfire, McKendricks, Aqua Blue and many more please go to their website to see all the great restaurants that will be there and to to get your tickets. They sell out every year so get those tickets now. The website is www.choa.org/todNext up we had on Alon Balshon, Pastry Chef and owner of Alon's Bakery which is coming to the Perimeter Mall area in February. Alon opened the first Alon's Bakery in 1992 in Virginia Highlands.  Over the years, the store expanded in size and scope and now his second location is just a couple of weeks away. Inspired by specialty markets in Europe and New York, Alon was passionate to bring a full service gourmet market to the Virginia Highlands. Since it's opening, Alon’s has become a neighborhood and city favorite receiving high accolades from Gourmet Magazine, Atlanta Magazine, the Atlanta Journal Constitution and Creative Loafing. For more information please go to their website www.alons.com Then we closed the show with Jeff Trump owner of one of Sandy Springs' favorite restaurants, Brooklyn Cafe. Jeff has been in the restaurant business for a long time. Before purchasing Brooklyn Cafe he was with the Houston's Restaurant organization for 16 years. Jeff is a big believer in giving back and has been instrumental in raising over $100,000 for local non-profit organizations. The menu at Brooklyn Cafe changes seasonally but always features the freshest fish and vegetables and over 90% of the sauces and dressings are mad in house. They also have an extensive wine list that is selected in order to match the food served on the menu. Jezebel Magazine puts rates it as one of the Top 100 Restaurants in Atlanta. they have received  the Zagat Guide Award of Distinction as one of the Top 40 Most Popular Restaurants in Atlanta. And the Atlanta Journal Constitution calls Brooklyn Cafe "Unpretentious and Gutsily good" and "An Atlanta institution." For more information about Brooklyn Cafe, including their menu, please go to their website www.brooklyncafe.com. Also if you know of a business in Atlanta that we should know about please email Amy Otto at Amy @ atlantabusinessradio.com and we will try and get them on the show.